---
schema_version: "secwatch.filing_event.v1"
accession: "0001013762-23-003856"
form_type: "8-K"
ticker: "KTTA"
cik: "0001841330"
company_name: "Pasithea Therapeutics Corp."
filed_at: "2023-10-13T23:59:59+00:00"
generated_at: "2026-06-10T00:10:19.122902+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Pasithea Therapeutics sets 2023 annual meeting for Nov 29; shareholder proposal deadline Oct 23

## Summary
- Annual meeting set for November 29, 2023; proxy materials to be delivered around October 23, 2023.
- Rule 14a-8 shareholder proposals must be received by October 23, 2023, at company's Miami Beach office.
- Bylaw director nominations and other proposals due by October 23, 2023.
- Universal proxy rule notices for non-company nominees also due by October 23, 2023.

## SEC filing metadata
- accession: 0001013762-23-003856
- form_type: 8-K
- ticker: KTTA
- cik: 0001841330
- company_name: Pasithea Therapeutics Corp.
- filed_at: 2023-10-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.08
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1841330/000101376223003856/0001013762-23-003856-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1841330/000101376223003856/ea186699-8k_pasithea.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001013762-23-003856
- JSON: https://secwatch.observer/filing/0001013762-23-003856.json
- Plain text: https://secwatch.observer/filing/0001013762-23-003856.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.